mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.03 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.03 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.03 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |